SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001640334-24-001681
Filing Date
2024-11-12
Accepted
2024-11-12 11:38:43
Documents
2
Period of Report
2024-11-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A lxrp_pre14a.htm PRE 14A 520281
2 lxrp_pre14aimg2.jpg GRAPHIC 10552
  Complete submission text file 0001640334-24-001681.txt   536162
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: PRE 14A | Act: 34 | File No.: 001-39874 | Film No.: 241445628
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)